ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • Clin Pharmacol Biopharm 2023, Vol 12(5): 335
  • DOI: 10.4172/2167-065X.1000335

Nanotechnology in Pharmaceutical Delivery System

Zhen Huang*
Department of Pharmaceutical Sciences Ulster University, Ireland
*Corresponding Author : Zhen Huang, Department of Pharmaceutical Sciences Ulster University, Ireland, Email: zhen.huang@uth.tmc.edu

Received Date: May 01, 2023 / Published Date: May 31, 2023

Abstract

Nanotechnology has revolutionized the field of drug delivery in the pharmaceutical industry. With the development of Nano scale particles and structures, drugs can now be targeted and delivered to specific sites within the body with greater precision and efficacy. One of the key advantages of nanotechnology in drug delivery is the ability to increase drug solubility, bioavailability, and stability. This is achieved by encapsulating drugs in Nano scale particles, which can protect them from degradation and enhance their absorption in the body. Additionally, nanoscale drug delivery systems can be designed to release drugs in a controlled manner, ensuring sustained therapeutic effects and minimizing potential side effects. Furthermore, nanotechnology-based delivery systems can be engineered to selectively target diseased cells or tissues, thereby reducing off-target effects and improving treatment outcomes. Overall, the use of nanotechnology in pharmaceutical delivery systems holds great promise for improving the effectiveness and safety of drug therapies. As such, it is an area of active research and development in the pharmaceutical industry.

Citation: Huang Z (2023) Nanotechnology in Pharmaceutical Delivery System. Clin Pharmacol Biopharm, 12: 335. Doi: 10.4172/2167-065X.1000335

Copyright: © 2023 Huang Z. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top